February 22, 2024

Smart Implantable Pumps Market Surges in Response to Changing Healthcare Landscape

In a comprehensive study aimed at shedding light on the dynamic landscape of the global smart implantable pumps market, a report has been released with insights that promise to reshape the healthcare industry during the forecast period.

Shooting Rates of Implantation Surgeries Drive Smart Implantable Pumps Market Growth

The smart implantable pumps market is experiencing a remarkable surge, propelled by a combination of factors. High prevalence and incidence of chronic diseases such as spasticity and chronic pain, a growing senior population susceptible to chronic ailments, increasing health awareness, rising healthcare costs, and favorable reimbursement policies are the driving forces behind this growth. According to the World Health Organization (WHO), chronic diseases were projected to account for 57% of the global disease burden by the end of 2020, with this figure expected to rise due to population expansion and increasing incidence rates.

COVID-19 Impact: A Surge in Demand

The COVID-19 pandemic, while posing unprecedented challenges to healthcare systems worldwide, paradoxically led to a surge in demand for smart implantable pumps. With elective medical procedures delayed, patients turned to remote care solutions, including smart implantable pumps, insulin infusion pumps, and volumetric infusion pumps. These devices proved vital in treating patients, particularly those in intensive care units, during the pandemic.

Chronic Pain Cases Fuel Expansion

The increasing prevalence of chronic pain, heart failure, and hypertension is another key driver of the global smart implantable pumps market. These conditions often require medication delivery through pumps. Heart failure alone affects millions of people globally, and chronic pain affects a substantial portion of the population, making smart implantable pumps a crucial medical innovation.

Ambulatory Pumps in Home Care Settings

Smart implanted pumps have found a growing role in home care settings, allowing patients to receive necessary treatment in the comfort of their homes. This trend is driven by the rising prevalence of chronic diseases, increasing healthcare costs, and a shift towards cost-effective home healthcare solutions. Ambulatory smart implanted pumps are becoming more popular, contributing to market growth.

See also  Gas Hydrates Market Size Projected to Grow at 4.5% CAGR: Driven by Increasing Demand in Automotive and Transportation Sectors 2030

Challenges Remain: Lack of Wireless Access

Despite these promising developments, challenges persist. Wireless connectivity of smart implantable pumps with hospital systems is essential for improving patient safety and treatment accuracy. However, the lack of compatibility between smart infusion devices and hospital information systems, due to poor wireless connectivity and limited funding, remains a significant hurdle.

Emulsifiers Lead the Way

The emulsifiers category dominates the smart implantable pumps market, driven by the increasing prevalence of chronic conditions and hospital visits. Hospital visits have increased due to the growing number of patients with conditions such as pain and spasticity. The availability of various versions of implanted infusion pumps further supports this segment.

Cardiovascular Application Dominance

In 2021, the cardiovascular category led the market, reflecting the rising prevalence of heart diseases worldwide. Cardiovascular diseases are the leading cause of global mortality, underscoring the importance of this category in the smart implantable pumps market.

North America Leads the Charge

North America is at the forefront of the smart implantable pumps market, driven by increasing cancer and diabetes cases, technological advancements, significant healthcare spending, and a growing senior population. The adoption of cutting-edge medical technology and a focus on data logging and patient monitoring contribute to the region’s market leadership.

Promising Outlook for Asia Pacific

Asia Pacific is poised for stable revenue growth in the smart implantable pumps market, thanks to its high adoption of advanced medical products, growing healthcare spending, and rising prevalence of lifestyle-related disorders. Emerging economies such as China, Japan, and India offer substantial growth opportunities, with their developed healthcare infrastructure and increasing demand for affordable therapies.

Global Smart Implantable Pumps Market: Key Players

Key players in the smart implantable pumps market include Abbott, Baxter, Cognos Therapeutics, Inc., Medtronic, Flowonix Medical, Inc., Terumo Europe NV, Intarcia Therapeutics, Inc., Fresenius Kabi (Ivenix), and tricumed Medizintechnik GmbH.

See also  Intumescent Coating Market Trends: Aiming for Fire Safety Excellence 2030

The global smart implantable pumps market is on a trajectory of remarkable growth, driven by a convergence of factors and technological advancements. As healthcare continues to evolve, smart implantable pumps are set to play a pivotal role in enhancing patient care and improving treatment outcomes.

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/smart-implantable-pumps-market

Our Trending Reports:

Centrifugal Pump Market


Infusion Pump Market



Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746



LinkedIn | Twitter

This press release first seen on Brilad